Austin, Texas, United States In 1982 was created Quintiles, which is appeared as Corporate Investor. The main office of represented Corporate Investor is situated in the Austin. The company was established in North America in United States.
The increased amount of exits for fund were in 2009. The fund is constantly included in less than 2 investment rounds annually. The usual things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2001.
We can highlight the next thriving fund investment areas, such as Medical, Pharmaceutical. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Israel. Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight D Pharm LTD., NitroMed.
The standard case for the fund is to invest in rounds with 8-9 partakers. The meaningful sponsors for the fund in investment in the same round are Rho Ventures, Vertex Ventures Israel, Vertex Ventures.
Related Funds
| Fund Name | Location |
| Benevolent Capital | California, Pacific Palisades, United States |
| Boyaa Interactive | China, Guangdong, Shenzhen |
| CMI Ventures | Dallas, Texas, United States |
| eFounders | France, Ile-de-France, Paris |
| Grains Valley Venture Capital | Beijing, Beijing, China |
| GVT Fund | Taipei, Taiwan |
| Halcyon Capital Management | New York, New York, United States |
| Inclusive Capital Partners | New York, New York, United States |
| Lake Capital | Chicago, Illinois, United States |
| Mingjia Capital | Beijing, Beijing, China |
| OCAS Ventures | Belgium, East Flanders, Oost-Vlaanderen |
| Pagoda Investment | Beijing, Beijing, China |
| PostScriptum Ventures | Luxembourg, Luxembourg |
| Resonant Venture Partners | Ann Arbor, Michigan, United States |
| Startup Lisboa | Lisboa, Lisbon, Portugal |
| The Exxel Group | Argentina, Buenos Aires, Distrito Federal |
| TREKK Opportunity Partners | California, Los Angeles, United States |
| University of Birmingham | Birmingham, England, United Kingdom |
| Velum Ventures | Antioquia, Colombia, Medellín |
| Yibei Software Engineering | China, Shanghai |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Bayhill Therapeutics | $35M | 04 May 2005 | California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Bayhill Therapeutics | $35M | 04 May 2005 | California, United States |
